Next-Generation Sequencing-Based Molecular Profiling Using Cell-Free DNA: A Valuable Tool for the Diagnostic and Prognostic Evaluation of Patients With Gastric Cancer

Overview

Journal Ann Lab Med

Specialty Pathology

Date 2023 Oct 26

PMID 37880993

Authors

Mi-Ae Jang

Affiliations

Soon will be listed here.

Citing Articles

Evaluation of the diagnostic and prognostic clinical values of circulating tumor DNA and cell-free DNA in pancreatic malignancies: a comprehensive meta-analysis.

Arayici M, Inal A, Basbinar Y, Olgun N Front Oncol. 2024; 14:1382369.

PMID: 38983931 PMC: 11231086. DOI: 10.3389/fonc.2024.1382369.

References

Telekes A, Horvath A . The Role of Cell-Free DNA in Cancer Treatment Decision Making. Cancers (Basel). 2022; 14(24). PMC: 9776613. DOI: 10.3390/cancers14246115. View

Pietrantonio F, Miceli R, Raimondi A, Kim Y, Kang W, Langley R . Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. J Clin Oncol. 2019; 37(35):3392-3400. DOI: 10.1200/JCO.19.01124. View

Kim B, Kim Y, Cho J, Lee K . Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer. Ann Lab Med. 2023; 44(2):164-173. PMC: 10628753. DOI: 10.3343/alm.2023.0187. View

Lengyel C, Hussain S, Trapani D, El Bairi K, Altuna S, Seeber A . The Emerging Role of Liquid Biopsy in Gastric Cancer. J Clin Med. 2021; 10(10). PMC: 8153353. DOI: 10.3390/jcm10102108. View

Shin S, Woo H, Kim J, M D Y, Lee K . Clinical Practice Guidelines for Pre-Analytical Procedures of Plasma Epidermal Growth Factor Receptor Variant Testing. Ann Lab Med. 2021; 42(2):141-149. PMC: 8548242. DOI: 10.3343/alm.2022.42.2.141. View

Grizzi G, Salati M, Bonomi M, Ratti M, Holladay L, De Grandis M . Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives. Int J Mol Sci. 2023; 24(11). PMC: 10254023. DOI: 10.3390/ijms24119421. View

Smyth E, Nilsson M, Grabsch H, van Grieken N, Lordick F . Gastric cancer. Lancet. 2020; 396(10251):635-648. DOI: 10.1016/S0140-6736(20)31288-5. View

Huffman B, Aushev V, Budde G, Chao J, Dayyani F, Hanna D . Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers. JCO Precis Oncol. 2022; 6:e2200420. PMC: 10530958. DOI: 10.1200/PO.22.00420. View

Zhong Y, Xu F, Wu J, Schubert J, Li M . Application of Next Generation Sequencing in Laboratory Medicine. Ann Lab Med. 2020; 41(1):25-43. PMC: 7443516. DOI: 10.3343/alm.2021.41.1.25. View

10.

Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G . Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022; 33(10):1005-1020. DOI: 10.1016/j.annonc.2022.07.004. View

11.

Cho S, Lee H, Jeon S, Kim Y, Kong S, Lee J . Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of Mutation in Advanced Non-Small Cell Lung Cancer. Ann Lab Med. 2023; 43(6):605-613. PMC: 10345179. DOI: 10.3343/alm.2023.43.6.605. View